RU-486 Suspension and Review Act of 2005

H.R. 1079, the RU-486 Suspension and Review Act of 2005, would have suspended the Food and Drug Administration's (FDA) approval of the drug mifepristone, which is used for the medical termination of early pregnancies. The bill would have also classified misoprostol as "misbranded" if its labeling included instructions for use in terminating a pregnancy.

Under this legislation, these restrictions would remain in place until the Government Accountability Office (GAO) conducted a full review of the FDA’s original approval process for mifepristone. If the review concluded that the approval followed all standard federal safety and procedural regulations, the drug’s approval would be reinstated; otherwise, it would remain unavailable for use in the United States.